Kristy Carpenter wins the “Drug Repurposing” NIDA Challenge and may have solved an even bigger issue with her research Read the story here: dbds.stanford.edu/kristy-carpe...

DBDS chair Sylvia Plevritis, Professor Nigam Shah, and Ph.D. student Timothy Keyes are featured in a video presented by CEO Satya Nadella during the Microsoft Build 2025 opening keynote on May 19. Watch it here: www.youtube.com/watch?v=DSOc....

Harrison Zhang, an MD-PhD student and incoming student in the DBDS PhD program this fall was recently awarded the Knight-Hennessy Scholarship. Congratulations, Harrison! Read the story here: knight-hennessy.stanford.edu/news/knight-...

Timothy Keyes from the Shah lab featured in Microsoft Source story, "Meet 4 Developers Leading the Way With AI Agents" Read the story here: news.microsoft.com/source/featu...

stat4onc.org/events/stat4... Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, & regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care. REGISTER NOW!

Roxana Daneshjou joins host Peter Lee on "The AI Revolution in Medicine, Revisited" podcast to discuss the responsible implementation of AI in healthcare, identifying mitigating bias in AI systems and also leveraging AI to better serve patient needs. Listen here: www.microsoft.com/en-us/resear...

AI Frontiers of Healthcare and Medicine Summit delivers exciting opportunity for collaboration between industry, biopharma, and DBDS Read the story here: dbds.stanford.edu/ai-frontiers...

James Zou in StatNews: AI agents in health care: Everything you need to know, but didn’t know how to ask AI agents differ from earlier generations of AI tools, but hurdles stand in the way of wider adoption Read more: www.statnews.com/2025/04/09/a...

Curt Langlotz in Washington Post: AI hasn't killed radiology, but it is changing it "AI is not a better kind of intelligence, it's a different kind of intelligence," Langlotz says. "A human plus a machine is better than either one alone." Read more here: wapo.st/4jk7cmB

Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, and regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care. REGISTER NOW! stat4onc.org/events/stat4...

Alumna Daisy Ding, et al., introduce MESA, a spatial omics framework that integrates multiomics data to study the spatial architecture of tissues in health and disease, was pubbed by Nature Genetics. This study, in part, was based on Ding’s DBDS Ph.D thesis. www.nature.com/articles/s41...

Nima Agheepour in Nature Medicine: AI can help doctors give intravenous nutrition to preemies An algorithm that learned from tens of thousands of nutrition prescriptions for premature babies could reduce medical errors.... Read it here: med.stanford.edu/news/all-new...

"Auditing the inference processes of medical-image classifiers by leveraging generative AI and the expertise of physicians" by Roxana Daneshjou (et all) was featured on the latest cover of Nature Biomedical Engineering. www.nature.com/natbiomedeng...

Zou Lab launches MedArena, a free platform for clinicians to use and compare frontier LLMs MedArena is a free platform for clinicians to use and compare how frontier LLMs work on medical queries. Check it out at: medarena.ai/login

Experimental Design: AI for Science, April 3-4

DBDS' James Zou awarded Overton Prize. Awarded by ISCB, the prize recognizes the research, education, and service accomplishments of early to mid-career scientists who are emerging leaders in computational biology. dbds.stanford.edu/james-zou-wi...

“Experimental Design: AI for Science” at Stanford 4/3-4/4. The workshop focuses on theory/methodology of AI-based experimental design & has an exciting lineup of speakers including David Baker, Nobel Prize winner. Faculty, students & postdocs invited. More information: edai4science.github.io

Dr. Mikel Hernaez at CIMA & Gevaert lab benchmarked inductive and transductive methods for drug target interaction discovery: Transductive methods don't lead to inflated performance when traditionally evaluated, making them unsuitable for drug repurposing. www.nature.com/articles/s42...

Grand Rounds, Nigam Shah, 2/25 Time: 9:00-10:00am PT Format: Live webinar presentation and Q&A Registration: Open to the Stanford and AIMI affiliate community Register Here: stanford.zoom.us/webinar/regi...

Incredibly grateful and honored to receive the 2025 Overton Prize ♥️ Surreal to follow the steps of my science heroes🙏 Truly, credit goes to my amazing students, collaborators and mentors who make research so inspiring! Also underscores the value of open academic environment that make this possible

Christina Curtis in the Stanford Report: Studying DNA variations in breast cancer tumors could improve treatment and recurrence screening Read it here: news.stanford.edu/stories/2025...

Manny Rivas and Larissa Lauer in BioRx: Unified meta regression models for rare variant association studies Rare variant association studies (RVAS) of complex traits have emerged as a powerful approach to advance drug discovery and diagnostics. Read more here: www.biorxiv.org/content/10.1...

James Zou: "The rise of agentic AI teammates in medicine," The Lancet "Medicine is in the dawn of a fundamental shift from using artificial intelligence (AI) as tools to deploying AI as agents..." Read more here: www.thelancet.com/journals/lan...

“This is a new era for us,” Chair of the Department of Biomedical Data Science Sylvia Plevritis began, opening the third annual Collaboration & Careers Forum on January 16, 2025. Read the story here: dbds.stanford.edu/collaboratio...

Purvesh Khatri and BMI postdoc Tim Sweeney have been working on developing blood-based signatures for presence, type, and severity of infection for 7 years. The signatures were licensed by Inflammatix, Inc. This week, a test based on those signatures, TriVerity, received and FDA clearance. Congrats!

The Gevaert Lab has developed SEQUOIA, a transformer model that predicts cancer transcriptomic profiles from whole slide images, enabling cost-effective genetic insights from H&E images.  www.nature.com/articles/s41...

Careers and Collaboration Forum 2025 External partners panel delivers a riveting conversation on “AI Frontiers in Healthcare and Medicine: Hype and Reality.”

WP: Doctors are using AI. Will it make healtchcare better or break it? “I recognize the health-care system is broken. Access to care is a huge issue. Doctors make mistakes. I hope AI can solve that,” Daneshjou says. Read the story here: www.washingtonpost.com/technology/2...

Excited to share our new study of #genomics🧬, #EHR📈 + treatment outcomes of 78K patients across 20 #cancers! We identified >700 mutations predicting which drugs💊 are effective for individual patients. Our #ML model predicts who responds well to immunotherapies. #precisioncancer

When are we going to get policies that limits or regulates this!!

The Zou Group is very excited to have a new paper on spatial single-cell aging clocks published in Nature, led by DBDS Ph.D. student Eric Sun. Read more here: www.nature.com/articles/s41....

Zou Group: 11 papers published in Neurips 2024 The Zou group is excited to share that they have 11 papers published in Neurips 2024, one of the main AI conferences. The Thirty-Eighth Annual Conference on Neural Information Processing Systems: neurips.cc Congrats!